Glucocorticoid receptor–Erythropoietin receptor complex (GR–EPOR complex)

The Glucocorticoid receptor–Erythropoietin receptor (GR–EPOR) complex is a specialized signaling unit formed by the physical and functional interaction of the nuclear glucocorticoid receptor (NR3C1) and the cytokine erythropoietin receptor (Flygare J, et al., Blood, 2011). This complex plays a pivotal role in stress erythropoiesis, where it facilitates the rapid expansion of early erythroid progenitor cells, specifically Burst-Forming Unit-Erythroid (BFU-E) cells (Narla A, et al., Blood, 2011). Upon activation by glucocorticoids, the GR interacts with the EPOR signaling machinery, often involving the JAK2/STAT5 pathway, to promote progenitor self-renewal and delay terminal differentiation (Heidari N, et al., 2012). This synergy is essential for the body's ability to recover from acute anemic stress or hypoxia (UniProt P04150, P19235). In clinical practice, the GR–EPOR complex is the therapeutic target for glucocorticoids in treating Diamond-Blackfan anemia, a rare genetic disorder characterized by red cell aplasia (Lodish HF, et al., 2010). Drugs like dexamethasone exploit this interaction to stimulate red blood cell production when endogenous erythropoietin levels are insufficient or when progenitor sensitivity is impaired. However, targeting this complex with systemic steroids is limited by significant side effects, driving research into more selective modulators.

Other names

GR-EPOR complexNR3C1-EPOR complexGlucocorticoid receptor-Erythropoietin receptor signaling assembly

Synergistic activation of erythroid progenitor expansion via GR-mediated modulation of EPOR/JAK2/STAT5 signaling